Skip to main content

Fondation Botnar supporting further research into pediatric health

| News

Fondation Botnar supporting further research into pediatric health


The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the Fondation Botnar. With this, the University of Basel and Swiss Federal Institute of Technology in Zurich will both be able to establish three new professorships for pediatric health.

A group of adolescents in conversation in Tanga, Tanzania (image: Fondation Botnar)

The Botnar Research Centre for Child Health (BRCCH) in Basel now has the opportunity to significantly expand its research activities. Following a donation of 50 million Swiss francs from the Basel-based Fondation Botnar, six new professorships can be created, three of which will be based at the University of Basel and three at the Swiss Federal Institute of Technology in Zurich (ETH).

The research focus of the professorships will be on pediatric digital health. According to a press release jointly issued by the two universities, their research areas range from biomolecular diagnostics to the development, application and integration of state-of-the-art analysis methods, all the way through to investigating ethical and political framework conditions in digitized pediatric healthcare.

To the benefit of children all over the world

The two universities work with a couple of other partner institutions, namely the University Children’s Hospital Basel (UKBB) and the Swiss Tropical and Public Health Institute (Swiss TPH), at the BRCCH, which was founded in 2019. Up to this point, the Fondation Botnar has funded their research activities to the tune of 115 million Swiss francs overall. This funding is intended to benefit the healthcare of children all over the world, but especially in poorer countries. More than 400 researchers have been involved in projects to date.

In the years to come, the new professors and their research teams will be based at a new BRCCH site located on the University of Basel’s Life Sciences Campus. This is situated in close proximity to the Department of Biosystems Science and Engineering (D-BSSE) of ETH Zurich in Basel. “At the same time, we wish to emphasize that ETH and the University are determined to support the cutting-edge research at the BRCCH in the long-term”, explains Professor Torsten Schwede, Vice President for Research at the University of Basel, in the press release.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Do you have a question? We'd like to hear from you.